Skip to main content
Dr. Martens PLC logo

Dr. Martens PLC — Investor Relations & Filings

Ticker · DOCMF ISIN · GB00BL6NGV24 LEI · 213800QPT8YM6NQZPH28 IL Manufacturing
Open in API
Filings indexed 372 across all filing types
Latest filing 2025-07-14 Director's Dealing
Country GB United Kingdom
Listing IL DOCMF

About Dr. Martens PLC

https://www.drmartens.com

Dr. Martens PLC is an iconic global footwear brand with a heritage of over 60 years. The company designs, develops, procures, markets, and distributes footwear, recognized for its durability and distinctive style. Its products, particularly the original 1460 boot, are characterized by an air-cushioned sole (marketed as AirWair), grooved edges, and signature yellow welt stitching. Originally created as a durable work boot, the brand has evolved into a cultural icon, adopted by various subcultures and individuals worldwide as a symbol of rebellious self-expression and authenticity. The company sells its products to consumers in more than 60 countries through a multi-channel distribution strategy.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification of Transactions by Directors/Persons Discharging Managerial Responsibility' and details share acquisitions by PDMRs (Ije Nwokorie and Giles Wilson) under the Share Incentive Plan (SIP). It explicitly references compliance with 'Article 19 of the UK Market Abuse Regulation'. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which matches the definition for Director's Dealing (DIRS). The presence of the RNS Number and the closing statement about RNS being the news service of the London Stock Exchange confirms it is a regulatory disclosure, but DIRS is the most specific category.
2025-07-14 English
2025 AGM resolutions
AGM Information Classification · 99% confidence The document explicitly states it contains resolutions passed at the 'Annual General Meeting of the Company duly convened and held on Thursday 10 July 2025'. The content details specific Ordinary and Special Resolutions concerning directors' authority to allot shares (Resolution 18, 19, 20), the authority to purchase own shares (Resolution 21), and the notice period for general meetings (Resolution 22). This content is the official record of decisions made during the AGM, which aligns perfectly with the definition of 'AGM Information' (AGM-R). It is not a full Annual Report (10-K), an Earnings Release (ER), or a proxy statement (PSI), but the outcome of the meeting itself.
2025-07-10 English
Result of 2025 AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly titled 'RESULT OF ANNUAL GENERAL MEETING' and contains a detailed table showing the voting results for various resolutions (Ordinary and Special) presented at the AGM held on '10 JULY 2025'. This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'. The RNS Number format (5713Q) is typical for regulatory announcements, and the content is a direct result announcement, not a presentation (AGM-R) or a proxy solicitation document (PSI).
2025-07-10 English
AGM Trading Update
AGM Information Classification · 98% confidence The document is titled 'Dr. Martens plc - AGM Trading Update' and explicitly states that the company 'will hold its AGM at 09.30am today'. It provides a trading update concurrent with the AGM date. Since the primary focus is the Annual General Meeting (AGM) event, and it includes an update delivered at that time, the most specific classification is AGM Information (AGM-R). Although it contains trading update elements, the context ties it directly to the AGM proceedings.
2025-07-10 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is an official release identified by the 'RNS Number' and mentions the 'FCA's Disclosure Guidance and Transparency Rule 5.6.1'. The core content provides the 'Total Voting Rights' (966,315,401 shares) which serves as the denominator for shareholder notification calculations. This type of mandatory regulatory disclosure regarding share capital structure and voting rights, especially when issued via RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights' disclosure, and it is not a declaration of voting results (DVA) but rather a statement of the total number of shares eligible to vote. Given the source (RNS) and the nature of the announcement, RNS is the most appropriate classification.
2025-07-04 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions by Directors/PDMRs (Persons Discharging Managerial Responsibility) regarding the grant of performance share awards under a Long Term Incentive Plan. It follows the standard UK Market Abuse Regulation (MAR) disclosure format for director dealings. While it mentions the Annual Report, the core purpose of this specific filing is to report insider share-related transactions, which aligns perfectly with the 'Director's Dealing' (DIRS) category.
2025-06-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.